• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » Synchron debuts BCI-enabled, thought-controlled iPad experience through Apple collab

Synchron debuts BCI-enabled, thought-controlled iPad experience through Apple collab

August 4, 2025 By Sean Whooley

Synchron-iPad
A screengrab from the Synchron demonstration video.

Synchron today presented the first-ever public demonstration of an individual using an Apple iPad controlled entirely by thought.

The experience leverages Apple’s built-in accessibility features and new brain-computer interface human interface device (BCI HID) protocol. Synchron shared in May that it would become the first BCI maker to achieve native integration with the new Apple protocol.

Through their collaboration, Synchron and Apple sought to enable users implanted with Synchron’s Stentrode BCI system to control an iPhone, iPad and Apple Vision Pro directly with their thoughts. It requires no physical movement or voice commands. This added to last year’s collaboration pairing Stentrode with the Apple Vision Pro.

Mark, a participant in Synchron’s COMMAND clinical study and a person living with ALS, used the BCI to operate the iPad. He navigated the device’s home screen, opened apps and composed text, all without using his hands, voice or eyes. This is possible through the BCI HID protocol from Apple. It leverages brain signals as a native input method for the first time.

“This is the first time the world has seen native, thought-driven control of an Apple device in action. Mark’s experience is a technical breakthrough, and a glimpse into the future of human-computer interaction, where cognitive input becomes a mainstream mode of control,” said Dr. Tom Oxley, CEO and founder, Synchron.

Join us at DeviceTalks West — Oct. 15–16, 2025 in Santa Clara, California — for our panel exploring the future of neurotech featuring Kurt Haggstrom, CCO of Synchron. Register at West.DeviceTalks.com.

Apple’s built-in accessibility feature, Switch Control, along with Stentrode, enabled Mark’s use of the iPad. Stentrode — which is implanted through an endovascular approach — detects motor intention from blood vessels within the brain. Synchron says its BCI is the only one tapping into blood vessels to capture signals from the brain. The implant goes on the surface of the motor cortex of the brain via the jugular vein.

Synchron designed the system to allow for closed-loop communication. This enables an iPad, iPhone or Apple Vision Pro to share contextual screen data with the BCI decoder. In turn, it optimizes real-time performance to enable precise, intuitive control using just neural signals.

“When I lost the use of my hands, I thought I had lost my independence,” said Mark. “Now, with my iPad, I can message my loved ones, read the news, and stay connected with the world, just by thinking. It’s given me part of my life back.”  

Synchron said the demonstration marks “a major advancement in assistive technology.” The company believes it offers a glimpse at the future of human-computer interaction. Additionally, it continues controlled rollouts of the BCI HID experience with clinical participants and expects broader availability to come.

“This marks a critical step in making BCI technology practical, scalable, and integrated into the global consumer ecosystem, moving beyond clinical trials into everyday life,” the company said.

Filed Under: Brain-Computer Interface (BCI), Digital Health, Featured, Health Technology, Implants, Neurological, Software / IT Tagged With: Apple, Synchron

More recent news

  • Citi downgrades Boston Scientific as cyberattack recovery compounds competitive pressure
  • Autonomix taps former Medtronic FDA counsel head for board of directors
  • Medtronic strengthens robotic surgery position with Cornerstone deal, analysts say
  • Science Corp. names president as it looks to roll out vision-restoring implant
  • Mindray looks to fill hospital ventilator gap left by Philips’ exit

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy